Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen-receptor positive breast cancer patients. An update at 7 years of the 1st GROCTA (breast cancer adjuvant chemo-hormone therapy cooperative group) trial
Titel:
Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen-receptor positive breast cancer patients. An update at 7 years of the 1st GROCTA (breast cancer adjuvant chemo-hormone therapy cooperative group) trial
Auteur:
Boccardo, F. Rubagotti, A. Amoroso, D. Sismondi, P. Genta, F. Nenci, I. Piffanelli, A. Farris, A. Castagnetta, L. Traina, A. Cappellini, M. Pacini, P. Sassi, M. Malacarne, P. Donati, D. Mustacchi, G. Galletto, L. Schieppati, G. Villa, E. Bolognesi, A. Gallo, L. other participants in the Grocta,